Back to Results
First PageMeta Content
Selective serotonin reuptake inhibitors / Organofluorides / Organochlorides / Psychoactive drugs / Treatment of bipolar disorder / Antidepressant / Paroxetine / Venlafaxine / Serotonin reuptake inhibitor / Chemistry / Psychiatry / Organic chemistry


Open Document

Share Result on Facebook

City

Amsterdam / Washington / Bradenton / Rockville / New York / Tallahassee / London / /

Company

Newsweek / Eli Lilly / Cambridge University Press / NBC / GlaxoSmithKline / Irish Times / the New York Times / Creative Commons / American Psychiatric Press / /

Country

United States / /

Currency

USD / /

/

Facility

Arch Gen Psychiatry / National Institute / US National Institute of Mental Health Laboratory of Clinical Science / Harvard University / Public Library of Science / New York University / Florida State University College of Social Work / Lake Erie College of Osteopathic Medicine / /

IndustryTerm

pharmaceutical industry / directto-consumer advertising / disseminated advertising campaign starring / advertising campaigns / Web Medication Selected Content / Lack energy / advertising incompatible / pharmaceutical company advertisements / treatment of depression / nervous systems / chemical imbalance / pharmaceutical / direct-to-consumer advertising / treatment of major depressive disorder / natural chemicals / neurotransmitter systems / chemical balance / chemical serotonin / consumer advertising / /

MedicalCondition

disorder / obsessivecompulsive disorder / posttraumatic stress disorder / mental disorder / anxiety disorder / psychiatric disorders / mild depression / Depression / rash / disorders / major depressive disorder / headaches / panic disorder / serotonergic dysfunction / mental illness / Mood disorders / affective disorders / Mental Disorders / social anxiety disorder / disease / psychiatric disorder / premenstrual dysphoric disorder / adjustment disorder / severe depression / Chronic anxiety / obsessive-compulsive disorder / /

MedicalTreatment

Cognitive therapy / placebos / /

NaturalFeature

Forest Pharmaceuticals / /

Organization

Cambridge University / New York University / British Association for Psychopharmacology / US National Institute of Mental Health Laboratory of Clinical Science / Lake Erie College of Osteopathic Medicine / American Psychiatric Association / Food and Drug Administration Division of Drug Marketing / Advertising / and Communications / FDA / United Kingdom Parliament / Harvard Medical School / Society for Biological Psychiatry / Harvard University / Food and Drug Administration / Brown University / German Medical Board / Irish Medical Board / Florida State University College of Social Work / Department of Health and Human Services / House of Commons / Stanford / National Institute for Clinical Excellence / /

Person

Francisco Moreno / David Burns / Joseph Glenmullen / Joseph Schildkraut / Irving Kirsch / Amine / Stephen M. Stahl / Elliot Valenstein / Jonathan Leo / Jeffrey R. Lacasse / David Healy / Psychiatrists Pedro Delgado / Margaret Shear / Biological Psychiatry / Arch Intern / John Horgan / Peter Kramer / Kenneth Kendler / /

Position

Psychiatrist / rst author / original author / General / secretary / historian / author / Professor Emeritus / Science writer / chemical messenger / emperor / United States General / United Kingdom Health Minister / chairman / /

Product

Sarafem / Escitalopram / Fluoxetine / Celexa / Remeron / Paxil / Effexor / Zoloft / Prozac / LEXAPRO / World Wide Web Medication / /

ProvinceOrState

Connecticut / California / Maryland / Florida / North Carolina / Massachusetts / /

PublishedMedium

PLoS Medicine / Newsweek / Public Library of Science / Consumer Reports / Clinical Science / the New York Times / Free Press / Contemporary / /

RadioStation

Andrews AM / /

Technology

Neuroscience / html / pdf / http / /

URL

www.fda.gov / www.celexa / www.publications.parliament.uk/pa / www.consumerreports.org / www.gao / www.medscape.com / www.paxil.com/about/ab_trt.html / www.fda / http /

SocialTag